ASO Author Reflections: Neoadjuvant Immunotherapy for Metastatic Melanoma Patients: The Train has Left the Station! Dougherty K. Ann Surg Oncol 2026 Jul 14. doi: 10.1245/s10434-026-20196.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dougherty K. ASO Author Reflections: Neoadjuvant Immunotherapy for Metastatic Melanoma Patients: The Train has Left the Station! Ann Surg Oncol 2026 Jul 14. doi: 10.1245/s10434-026-20196.
PMID: 42448973